Genetic diseases
> Cleveland-based startup Abeona Therapeutics has raised $750,000 in seed financing to complete preclinical development of therapies for children with Sanfilippo syndrome, a rare but often fatal genetic disorder. Release
> Galapagos has selected GLPG1837 as its preclinical candidate for cystic fibrosis. The Belgium-based biotech expects to begin the first clinical trial of the drug in 2014. Release
Diabetes
> Researchers from Wayne State University in Detroit have found a way to heal skin and corneal wounds in diabetic patients. Release
CNS disorders
>A study from the University of Nottingham has found a new biomarker for Alzheimer's--a rare genetic mutation that strongly increases the risk of developing the disease. Item
Stem cells
> A team from Duke University has developed a 3-D fabric "scaffold" to hold injected stem cells intended to be used to grow new cartilage tissue. Release
Immune disorders
> A protein complex identified by investigators at St. Jude Children's Research Hospital helps kick the immune system into gear within the first 24 hours of an infection. Release